Rury R Holman

43PUBLICATIONS

129CO-AUTHORS

Gene and molecular therapyEpidemiological methodsMajor global burdens of diseasePharmaceutical delivery technologiesBehavioural epidemiology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (43)

Sort by Publication Date:

|May 20, 2026

Precision Prescribing of SGLT2 Inhibitors in Individuals With Type 2 Diabetes for Primary Prevention of Heart Failure: Model Development and Validation Study.

|Nov 20, 2025

The Role of Adaptive and Innovative Trial Designs in Diabetes Research: A Scoping Review.

Ashni Goshrani, Rose Lin, Leonid Churilov

|Aug 28, 2025

International Variation in Case Fatality After Major Coronary or Cerebrovascular Events in Individuals With Type 2 Diabetes: Evidence From ADVANCE, TECOS, and EXSCEL.

Philip M Clarke, Xinyang Hua, Ruth L Coleman

|Jul 06, 2025

Utilization of Proteomic Measures for Early Detection of Drug Benefits and Adverse Effects.

Jessica Chadwick, Colin Berry, Meredith A Carpenter

|Mar 21, 2025

Response to Comments on Maddaloni et al. Osteoprotegerin, Osteopontin, and Osteocalcin Are Associated With Cardiovascular Events in Type 2 Diabetes: Insights From EXSCEL. Diabetes Care 2025;48:235-242.

Ernesto Maddaloni, Maggie Nguyen, Svati H Shah

|Mar 03, 2025

Identification of plasma proteomic markers underlying polygenic risk of type 2 diabetes and related comorbidities.

Douglas P Loesch, Manik Garg, Dorota Matelska

Pageof 8

Frequent Collaborators

Ruth L Coleman

Shelby D Reed

Naveed Sattar

Lindsay E Clegg

Robert C Penland

Hiddo J L Heerspink

John M Dennis

Angus G Jones

John B Buse

Helen A Dakin

Frequent Collaborators

Ruth L Coleman

Shelby D Reed

Naveed Sattar

Lindsay E Clegg